Package 51662-1270-1

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51662-1270-1
Digits Only 5166212701
Product NDC 51662-1270
Product ID 51662-1270_12004047-3162-77ac-e063-6294a90a77a3
Description

1 SYRINGE, PLASTIC in 1 CARTON (51662-1270-1) / 4 mL in 1 SYRINGE, PLASTIC

Marketing

Marketing Status
Marketed Since 2018-09-01
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "12004047-3162-77ac-e063-6294a90a77a3", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["898316"], "spl_set_id": ["74d94dbf-0567-6c15-e053-2991aa0ac6e4"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (51662-1270-1)  / 4 mL in 1 SYRINGE, PLASTIC", "package_ndc": "51662-1270-1", "marketing_start_date": "20180901"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "51662-1270_12004047-3162-77ac-e063-6294a90a77a3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1270", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "HF Acquisition Co. LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA075136", "marketing_category": "ANDA", "marketing_start_date": "20180901", "listing_expiration_date": "20261231"}